Biomarkers for kidney cancer
This interview from Practice Update with Dr Neeraj Agarwal from [...]
Patient engagement in clinical development
The National Institute for Health Research (NIHR) is rolling out [...]
NHS to update technology
The Health Secretary, Matt Hancock, has announced major plans to [...]
First CAR-T therapy for kidney cancer shows signs of efficacy
Chimeric antigen receptor T-cell (CAR-T) therapy is an immunotherapy specifically [...]
Predictive biomarkers in metastatic kidney cancer
A review published in European Urology Focus looks at tools [...]
Intermittent nivolumab in the second line warrants further investigation
A recent phase 2 trial published in Journal for Immunotherapy [...]
Clinical course and treatment outcomes of sarcomatoid chromophobe RCC
Chromophobe renal cell carcinoma (RCC) is a rare subtype of [...]
Barriers to cancer clinical trial enrolment
This review presents the findings of a meta-analysis of 13 [...]
Neoadjuvant axitinib to allow partial nephrectomy of cT2a renal tumours
A phase 2 study published in the British Journal of [...]
Real-world outcomes of nivolumab and cabozantinib for metastatic kidney cancer
A retrospective study using data from the International Metastatic Renal [...]
